NeuroVasc Technologies

About:

NeuroVasc Technologies is a medical device company that develops a catheter-based technology to treat neurovascular diseases.

Website: http://www.neurovasctechnologies.com/

Top Investors: Shangbay Capital, Weigao Group

Description:

NeuroVasc Technologies is a medical device company that develops a catheter-based technology designed to treat neurovascular diseases. The company develops a comprehensive portfolio development strategy to bring tools to the community to facilitate treatment options for patients suffering from a stroke. NeuroVasc Technologies was founded in 2015 and is headquartered in Laguna Hills, California.

Total Funding Amount:

$42.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Laguna Hills, California, United States

Founded Date:

2015-01-01

Contact Email:

RA(AT)neurovasctechnologies.com

Founders:

Jianlu Ma

Number of Employees:

1-10

Last Funding Date:

2020-02-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai